1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carbonitrile CAS:2158267-70-8

1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carbonitrile plays a pivotal role as an intermediate in the synthesis of complex, bioactive compounds with potential pharmaceutical applications. Its incorporation into molecular frameworks enables researchers to explore new drug candidates targeting diverse therapeutic areas such as kinase inhibitors, fluorescent probes, or materials chemistry applications. The presence of the pyrazole core and the dioxaborolane group introduces specific reactivity and pharmacophoric properties, making it valuable for medicinal chemistry research. In drug discovery efforts, this compound may serve as a starting point for designing potential drug candidates, leveraging its structural features to modulate biological activity and pharmacokinetic properties. Additionally, the dioxaborolane functional group offers opportunities for further derivatization and cross-coupling chemistry, potentially leading to the development of novel molecules with enhanced biological properties and improved pharmacokinetic profiles. Furthermore, in academic and industrial settings, researchers can utilize this building block to prepare libraries of diverse derivatives for structure–activity relationship studies, facilitating the identification of lead compounds with desired biological effects. Its role in chemical synthesis extends to the production of pharmaceutical intermediates and the development of novel synthetic methodologies, showcasing its broad utility across scientific disciplines. Overall, 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carbonitrile plays a pivotal role in the pursuit of innovative drug discovery and chemical research, providing a platform for the development of diverse biologically active molecules and pharmaceutical intermediates.